全球迷走神經刺激市場

預計到 2030 年全球迷走神經刺激市場規模將達到 8.592 億美元

全球迷走神經刺激市場規模預計在2024年為5.157億美元，到2030年將達到8.592億美元，在2024-2030年的分析期內，複合年成長率為8.9%。植入式迷走神經刺激裝置是本報告分析的細分市場之一，預計其複合年成長率為7.7%，到分析期結束時規模將達到5.486億美元。體外迷走神經刺激裝置細分市場在分析期間的複合年成長率預計為11.2%。

美國市場預計將達到 1.405 億美元，而中國市場預計將以 12.0% 的複合年成長率成長

美國迷走神經刺激市場規模預計2024年達到1.405億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到1.713億美元，在2024-2030年的分析期間內，複合年成長率為12.0%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為6.4%和7.7%。在歐洲，預計德國市場的複合年成長率約為6.9%。

全球迷走神經刺激市場—主要趨勢與促進因素摘要

為什麼迷走神經刺激處於神經調節突破的前沿？

迷走神經刺激 (VNS) 是神經調節領域的一種創新方法，近年來發展勢頭迅猛，為治療複雜的神經和精神疾病帶來了希望。 VNS 最初核准用於治療難治性癲癇，後來治療範圍逐漸擴大到抗治療性憂鬱症、偏頭痛、叢集性頭痛，甚至發炎和心臟疾病。這種日益成長的臨床多樣性是由於迷走神經在整個自主神經系統中具有廣泛的生理影響，使得 VNS 能夠調節腦迴路、神經傳導物質釋放和發炎路徑。現代 VNS 設備包括植入式和非侵入式系統，其中經皮VNS (tVNS) 因其易於使用和降低手術風險而越來越受歡迎。經皮VNS 透過耳朵或頸部的手術導線或電極向迷走神經傳遞受控電脈衝。隨著越來越多的患者尋求非藥物的長期治療方法，VNS 已成為可行的解決方案，特別適用於慢性、抗治療性疾病。隨著臨床證據的增多，越來越多的醫生將迷走神經刺激 (VNS) 納入多學科照護模式，隨著治療適應症的擴大，患者的興趣也日益成長。這種轉變凸顯了迷走神經刺激 (VNS) 作為個人化神經標靶治療支柱的重要性日益增強。

技術創新如何提高 VNS 設備的有效性和可近性？

技術進步在重新定義迷走神經刺激裝置的功能和應用範圍方面發揮著至關重要的作用。最新一代植入式迷走神經刺激系統 (VNS) 具有響應式（或閉合迴路）刺激功能，可根據心率和腦電圖 (EEG) 數據等生理指標即時調整電脈衝。此類智慧型裝置可改善治療效果，同時最大限度地減少副作用，這是患者依從性的關鍵因素。非侵入式治療方案，尤其是穿戴式迷走神經刺激系統 (tVNS)，為治療方案帶來了靈活性，減少了手術需求，並實現了居家治療。電池壽命、裝置可編程性和小型化的顯著提升也提高了使用者的舒適度和便利性。與行動應用程式和雲端基礎分析的整合實現了遠端監控、臨床醫生反饋和個人化給藥方案，為持續護理模式打開了大門。一些 VNS 平台正在探索機器學習演算法，以根據患者的獨特反應微調治療參數。此外，與其他醫療技術（例如數位心理健康工具和睡眠監測應用程式）的互通性，正在為更全面的患者支援提供支援。這些創新正在將 VNS 從高度專業化的醫院治療方法轉變為更廣泛、更適應性強的解決方案，並且在門診病人和遠端醫療環境中的相關性越來越強。

監管部門的核准和研究管道在市場成熟度中將發揮什麼作用？

圍繞迷走神經刺激的監管和臨床試驗格局正在迅速發展，透過提高可靠性、檢驗和商業化機會來促進市場擴張。美國FDA 和歐洲 CE 標誌當局已經擴大了 VNS 設備對各種適應症的核准，並刺激了老牌醫療技術公司和新興企業的創新。例如，非侵入性 VNS 設備已經進入頭痛症市場，並獲得了 PTSD 和發炎性腸道疾病疾病等疾病的突破性醫療設備稱號。這些里程碑不僅證明了有效性和安全性，而且還支持加速進一步發展的道路。同時，一個強大的臨床試驗流程正在探索 VNS 在耳鳴、纖維肌痛、焦慮、類風濕性關節炎甚至與阿茲海默症相關的認知能力下降等疾病中的應用。這種不斷擴大的潛在用途組合凸顯了 VNS 療法的適應性，並增強了其對投資者、醫療保健提供者和患者的價值提案。公共和私人對神經調節研究的資助也在增加，這促進了產學合作，旨在探索下一代迷走神經刺激 (VNS) 傳輸機制，包括生物電子植入和基因調控神經介面。隨著這些研究的持續推進，由此產生的數據可能會鞏固迷走神經刺激 (VNS) 在臨床指南中的地位，鼓勵擴大報銷框架，並進一步刺激市場採用。

哪些因素推動了全球對迷走神經刺激解決方案的需求？

迷走神經刺激市場的成長受到多種因素的驅動，這些因素與技術進步、治療多樣化、治療模式轉變和病人參與提高直接相關。癲癇和憂鬱症神經系統疾病在全球範圍內的盛行率不斷上升，尤其是在老化和抗治療性人群中，這導致對無需藥物負擔即可長期緩解症狀的替代療法的需求持續成長。非侵入性迷走神經刺激設備的普及和接受度不斷提高，降低了患者和醫療保健提供者的准入門檻，刺激了它們在門診病人和居家醫療環境中的應用。生物電子醫學和人們對迷走神經在發炎、壓力和情緒中的調節作用的認知不斷提高，也引起了臨床和健康角度的新興趣。醫療保健系統和保險公司正逐漸將神經調節視為一種具有成本效益的干涉措施，尤其是在慢性藥物治療和住院治療費用高昂的情況下。此外，個人化醫療趨勢和數位健康工具的整合使患者能夠更主動地管理治療，而VNS平台也擴大提供即時數據和自適應治療。醫療科技公司快速創新，加上良好的監管資格以及神經技術研究投入的不斷增加，使其市場足跡不斷擴展至北美、歐洲和亞太等快速成長的研發地區。綜合來看，這些發展使VNS成為全球治療領域強大且可擴展的解決方案。

部分

產品（植入式迷走神經刺激裝置、體外迷走神經刺激裝置）、生物材料（金屬、陶瓷、聚合物）、應用（癲癇、憂鬱症、偏頭痛）、最終用途（醫院、神經科診所、門診手術中心、研究中心）

受訪公司範例

• BioControl Medical
• Boston Scientific Corporation
• Cirtec Medical
• Cyberonics, Inc.
• electroCore, Inc.
• Endonovo Therapeutics, Inc.
• EnteroMedics Inc.
• Helius Medical Technologies, Inc.
• Inspire Medical Systems, Inc.
• LivaNova PLC
• Masimo Corporation
• Medtronic plc
• MicroTransponder Inc.
• Nevro Corp.
• NeuroMetrix, Inc.
• NeuroPace, Inc.
• NeuroSigma, Inc.
• Parasym Ltd
• SetPoint Medical Corporation
• tVNS Health GmbH

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口情況（成品和原始OEM）預測其競爭地位的變化。這種複雜多變的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Vagus Nerve Stimulation Market to Reach US$859.2 Million by 2030

The global market for Vagus Nerve Stimulation estimated at US$515.7 Million in the year 2024, is expected to reach US$859.2 Million by 2030, growing at a CAGR of 8.9% over the analysis period 2024-2030. Implantable VNS Device, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$548.6 Million by the end of the analysis period. Growth in the External VNS Device segment is estimated at 11.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$140.5 Million While China is Forecast to Grow at 12.0% CAGR

The Vagus Nerve Stimulation market in the U.S. is estimated at US$140.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$171.3 Million by the year 2030 trailing a CAGR of 12.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.4% and 7.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.9% CAGR.

Global Vagus Nerve Stimulation Market - Key Trends & Drivers Summarized

Why Is Vagus Nerve Stimulation at the Forefront of Neuromodulation Breakthroughs?

Vagus nerve stimulation (VNS) has gained critical momentum in recent years as a transformative approach within the broader field of neuromodulation, offering hope in the treatment of complex neurological and psychiatric conditions. Originally approved for refractory epilepsy, VNS has since expanded its therapeutic reach to include treatment-resistant depression, migraine, cluster headaches, and even promising applications in inflammatory diseases and cardiac disorders. This growing clinical versatility stems from the vagus nerve’s extensive physiological influence across the autonomic nervous system, enabling VNS to modulate brain circuits, neurotransmitter release, and inflammatory pathways. Modern VNS devices include both implantable and non-invasive systems, with transcutaneous VNS (tVNS) gaining favor for its ease of use and reduced procedural risks. These devices deliver controlled electrical impulses to the vagus nerve, either via surgical leads or external ear or neck-based electrodes. With an increasing number of patients seeking drug-free, long-term alternatives to conventional treatments, VNS has emerged as a viable solution, particularly in chronic and treatment-resistant conditions. As the body of clinical evidence grows, more physicians are integrating VNS into multidisciplinary care models, and patient interest is rising in parallel with expanded therapeutic indications. This shift underscores the growing importance of VNS as a pillar of personalized, neuro-targeted medicine.

How Are Technological Innovations Enhancing the Efficacy and Accessibility of VNS Devices?

Technological advancements are playing a decisive role in redefining the capabilities and reach of vagus nerve stimulation devices. The latest generation of implantable VNS systems now feature responsive or closed-loop stimulation, allowing real-time adaptation of electrical pulses based on physiological markers such as heart rate or electroencephalographic data. These intelligent devices improve therapeutic outcomes while minimizing side effects, a crucial factor in patient adherence. Non-invasive options, particularly tVNS wearables, have introduced flexibility in treatment schedules, reducing the need for surgery and enabling at-home therapy. Battery life, device programmability, and miniaturization have also seen significant improvements, contributing to enhanced comfort and convenience for users. Integration with mobile applications and cloud-based analytics allows remote monitoring, clinician feedback, and individualized dosing regimens, opening doors for continuous care models. Some VNS platforms are exploring machine learning algorithms to fine-tune therapy parameters based on patient-specific responses. Additionally, device interoperability with other health technologies, such as digital mental health tools or sleep monitoring apps, is enabling more holistic patient support. These innovations are transforming VNS from a highly specialized hospital-based therapy into a broader, more adaptable solution with growing relevance in both outpatient and telehealth environments.

What Role Do Regulatory Approvals and Research Pipelines Play in Market Maturation?

The regulatory and clinical trial landscape surrounding vagus nerve stimulation is rapidly evolving, fostering market expansion through increased trust, validation, and commercialization opportunities. The U.S. FDA and European CE Mark authorities have broadened approval for VNS devices across various indications, encouraging innovation among both established medtech companies and start-ups. For instance, non-invasive VNS devices have gained market entry for headache disorders and have received Breakthrough Device Designation for conditions such as PTSD and inflammatory bowel disease. These milestones not only validate efficacy and safety but also support accelerated pathways for further development. Concurrently, a robust pipeline of clinical trials is exploring VNS applications in disorders such as tinnitus, fibromyalgia, anxiety, rheumatoid arthritis, and even cognitive decline linked to Alzheimer's disease. This expanding portfolio of potential uses underscores the adaptability of VNS therapy and enhances its value proposition to investors, healthcare providers, and patients. Public and private funding for neuromodulation research is also growing, fueling academic-industry collaborations aimed at exploring next-gen VNS delivery mechanisms, including bioelectronic implants and gene-modulated neural interfaces. As these developments continue, the resulting data will solidify the role of VNS in clinical guidelines and encourage reimbursement frameworks to widen, further stimulating market adoption.

What Factors Are Driving the Global Demand for Vagus Nerve Stimulation Solutions?

The growth in the vagus nerve stimulation market is driven by several factors directly linked to technological advancements, therapeutic diversification, changing treatment paradigms, and increasing patient engagement. The rising global incidence of neurological disorders such as epilepsy and depression-especially among aging and treatment-resistant populations-is creating sustained demand for alternative therapies that offer long-term relief without pharmacological burden. The expanding availability and acceptance of non-invasive VNS devices have lowered the entry barrier for patients and providers alike, fueling adoption across outpatient and home care settings. Increased awareness of bioelectronic medicine and the vagus nerve’s regulatory role in inflammation, stress, and mood is also attracting new interest from both clinical and wellness perspectives. Healthcare systems and insurers are gradually aligning with neuromodulation as a cost-effective intervention, especially in cases where chronic medication and hospitalization costs are high. Furthermore, personalized medicine trends and the integration of digital health tools are empowering patients to manage their treatment more proactively, with VNS platforms increasingly offering real-time data and adaptive therapy. Rapid innovation from medtech companies, combined with favorable regulatory designations and growing investment in neurotechnology research, is expanding the market footprint across North America, Europe, and rapidly developing regions like Asia-Pacific. Collectively, these dynamics are positioning VNS as a powerful, scalable solution within the global therapeutic landscape.

SCOPE OF STUDY:

The report analyzes the Vagus Nerve Stimulation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Implantable VNS Device, External VNS Device); Biomaterial (Metallic, Ceramics, Polymeric); Application (Epilepsy, Depression, Migraine); End-Use (Hospitals, Neurology Clinics, Ambulatory Surgery Centers, Research Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

• BioControl Medical
• Boston Scientific Corporation
• Cirtec Medical
• Cyberonics, Inc.
• electroCore, Inc.
• Endonovo Therapeutics, Inc.
• EnteroMedics Inc.
• Helius Medical Technologies, Inc.
• Inspire Medical Systems, Inc.
• LivaNova PLC
• Masimo Corporation
• Medtronic plc
• MicroTransponder Inc.
• Nevro Corp.
• NeuroMetrix, Inc.
• NeuroPace, Inc.
• NeuroSigma, Inc.
• Parasym Ltd
• SetPoint Medical Corporation
• tVNS Health GmbH

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Vagus Nerve Stimulation - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Neurological and Psychiatric Disorders Drives Demand for Vagus Nerve Stimulation Therapies
  • Expansion of Non-Invasive VNS Devices Spurs Growth in At-Home and Outpatient Treatment Adoption
  • Advancements in Closed-Loop and Responsive Stimulation Technologies Strengthen the Business Case for Smart VNS Systems
  • FDA Approvals and Breakthrough Device Designations Propel Market Expansion Across New Therapeutic Indications
  • Growing Use of VNS in Treatment-Resistant Depression and Epilepsy Sustains Long-Term Market Growth
  • Integration of VNS With Wearables and Mobile Health Apps Generates Opportunities for Remote Monitoring Solutions
  • Increased Focus on Bioelectronic Medicine Throws the Spotlight on VNS as a Pillar of Neuromodulation Therapies
  • Consumer Preference for Drug-Free Chronic Condition Management Drives Adoption of Implant-Free VNS Alternatives
  • Emerging Applications in Cognitive Health and PTSD Generate Demand for Specialized VNS Protocols
  • Increasing Awareness of the Gut-Brain Axis and Autonomic Nervous System Function Enhances Interest in VNS Therapies
  • Global Aging Population and Rise in Neurodegenerative Diseases Create Sustainable Demand for VNS Interventions
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Vagus Nerve Stimulation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Implantable VNS Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Implantable VNS Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Implantable VNS Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for External VNS Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for External VNS Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for External VNS Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Neurology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Neurology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Neurology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Metallic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Metallic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Metallic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Ceramics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Ceramics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Ceramics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Polymeric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Polymeric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Polymeric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Epilepsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Depression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Migraine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• JAPAN
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• CHINA
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 77: China Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• EUROPE
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Vagus Nerve Stimulation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• FRANCE
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 104: France Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: France 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• GERMANY
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Germany 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Italy 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Italy 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 140: UK Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: UK 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: UK 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Spain 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Spain 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Russia 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Russia 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Vagus Nerve Stimulation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Australia 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Australia 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• INDIA
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 215: India Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: India 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: India 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: South Korea 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: South Korea 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Vagus Nerve Stimulation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Latin America 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Latin America 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Argentina 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Argentina 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Brazil 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Brazil 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Mexico 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Mexico 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Vagus Nerve Stimulation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Middle East 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 328: Middle East 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 331: Iran 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 340: Iran 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 343: Israel 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 352: Israel 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 367: UAE 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 376: UAE 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• AFRICA
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 391: Africa 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 400: Africa 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030

IV. COMPETITION